Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 54Active not recruiting 13Terminated 12Recruiting 10Unknown 8Withdrawn 6Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 3Interventional 2

Sponsor

Conditions

Breast Neoplasms 425Neoplasms 284Carcinoma, Non-Small-Cell Lung 274Colorectal Neoplasms 236Prostatic Neoplasms 173Lung Neoplasms 171Carcinoma, Hepatocellular 157Stomach Neoplasms 126Leukemia, Myeloid, Acute 120Pancreatic Neoplasms 118Multiple Myeloma 106Recurrence 100Uterine Cervical Neoplasms 97Squamous Cell Carcinoma of Head and Neck 89Neoplasm Metastasis 88Rectal Neoplasms 87Ovarian Neoplasms 81Triple Negative Breast Neoplasms 78Small Cell Lung Carcinoma 72Head and Neck Neoplasms 70Brain Neoplasms 70Glioblastoma 65Esophageal Neoplasms 65Endometrial Neoplasms 59Colonic Neoplasms 59Melanoma 56Hematologic Neoplasms 53Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Motor Activity 48Glioma 48

Interventions

lutetium Lu 177 dotatate 1Thyroidectomy 1Specimen Handling 1Neck Dissection 1High-Energy Shock Waves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Interventional × Carcinoma, Medullary × Clear all
NCT07612293 2026-05-28

STAGE-MTC Trial Thyroid Lobectomy With Ipsilateral Central Neck Dissection

Jonsson Comprehensive Cancer Center

Phase NA Not yet recruiting
100 enrolled

Carcinoma, Medullary

NCT06121271 2023-12-07

Trial of Lu-177 DOTATATE (Lutathera®) in Unlicensed Indications

University College, London

Phase 2 Not yet recruiting
110 enrolled

Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡